BLACK PATIENTS' REPRESENTATION IN MAJOR RANDOMIZED CONTROLLED TRIALS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

2021 ◽  
Vol 37 (10) ◽  
pp. S67-S68
Author(s):  
I Khayyat ◽  
T Huynh ◽  
H Khayyat
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Randomized Controlled Trials ◽  
Controlled Trials ◽  
Preserved Ejection Fraction ◽  
Randomized Controlled ◽  
Black Patients

scholarly journals SGLT 2 INHIBITORS: NEWER PARADIGMS IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION

2021 ◽  
Vol 9 (11) ◽  
pp. 1043-1046
Author(s):  
Shaista Alvi
Keyword(s):  
Diabetes Mellitus ◽  
Heart Failure ◽  
Ejection Fraction ◽  
Randomized Controlled Trials ◽  
Large Scale ◽  
Controlled Trials ◽  
Reduced Ejection Fraction ◽  
Randomized Controlled

Heart Failure is a growing concern now a days. Many drugs are available for the treatment of heart failure but still there is increasing prevalence of heart failure. SGLT 2 inhibitors were initially developed for diabetes mellitus but they are found to be effective for Heart Failure with reduced ejection also. Many large scale randomized controlled trials also confirmed this and now they are recommended in the treatment of heart failure with reduced ejection fraction.

Sign in / Sign up

Export Citation Format

Share Document